EP1868577A4 - Particules de lacidipine - Google Patents
Particules de lacidipineInfo
- Publication number
- EP1868577A4 EP1868577A4 EP06749977A EP06749977A EP1868577A4 EP 1868577 A4 EP1868577 A4 EP 1868577A4 EP 06749977 A EP06749977 A EP 06749977A EP 06749977 A EP06749977 A EP 06749977A EP 1868577 A4 EP1868577 A4 EP 1868577A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- lacidipine
- particles
- lacidipine particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN432CH2005 | 2005-04-15 | ||
| IN436CH2005 | 2005-04-15 | ||
| US68466805P | 2005-05-26 | 2005-05-26 | |
| US68469105P | 2005-05-26 | 2005-05-26 | |
| PCT/US2006/013783 WO2006113309A1 (fr) | 2005-04-15 | 2006-04-13 | Particules de lacidipine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1868577A1 EP1868577A1 (fr) | 2007-12-26 |
| EP1868577A4 true EP1868577A4 (fr) | 2009-12-09 |
Family
ID=37115465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP06749977A Withdrawn EP1868577A4 (fr) | 2005-04-15 | 2006-04-13 | Particules de lacidipine |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP1868577A4 (fr) |
| WO (1) | WO2006113309A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012142927A1 (fr) * | 2011-04-18 | 2012-10-26 | 合肥贝霓医药科技有限公司 | Procédé de purification de bloquants du canal calcique de type dihydropyridine et préparation de nanoparticules de ceux-ci |
| ITMI20131485A1 (it) | 2012-09-10 | 2014-03-11 | Rivopharm Sa | Composizione farmaceutica comprendente lacipidina e processo di preparazione |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5011848A (en) * | 1984-08-22 | 1991-04-30 | Glaxo, S.P.A. | 1.4-dihydro pyridines |
| WO2003101624A1 (fr) * | 2002-05-28 | 2003-12-11 | Battelle Memorial Institute | Depot electrostatique de particules issues de l'expansion rapide de solutions fluides supercritiques |
| WO2004009057A1 (fr) * | 2002-07-18 | 2004-01-29 | Astrazeneca Ab | Procede de preparation de dispersions de nanoparticules cristallines |
| WO2005014069A1 (fr) * | 2003-08-05 | 2005-02-17 | Phoqus Pharmaceuticals Limited | Revetement de dispositifs chirurgicaux |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1244728B (it) * | 1991-02-13 | 1994-08-08 | Glaxo Spa | Impiego medicamentoso di derivati diidropiridinici |
| SE9501384D0 (sv) | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
| GB9828721D0 (en) | 1998-12-24 | 1999-02-17 | Glaxo Group Ltd | Novel apparatus and process |
| GB0016040D0 (en) | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
| DE60210622T2 (de) | 2001-05-05 | 2007-04-05 | Accentus Plc | Bildung kleiner Kristalle |
| US7931022B2 (en) * | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
| GB0125604D0 (en) | 2001-10-25 | 2001-12-19 | Glaxo Group Ltd | Novel process |
| US20050095267A1 (en) * | 2002-12-04 | 2005-05-05 | Todd Campbell | Nanoparticle-based controlled release polymer coatings for medical implants |
-
2006
- 2006-04-13 EP EP06749977A patent/EP1868577A4/fr not_active Withdrawn
- 2006-04-13 WO PCT/US2006/013783 patent/WO2006113309A1/fr not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5011848A (en) * | 1984-08-22 | 1991-04-30 | Glaxo, S.P.A. | 1.4-dihydro pyridines |
| WO2003101624A1 (fr) * | 2002-05-28 | 2003-12-11 | Battelle Memorial Institute | Depot electrostatique de particules issues de l'expansion rapide de solutions fluides supercritiques |
| WO2004009057A1 (fr) * | 2002-07-18 | 2004-01-29 | Astrazeneca Ab | Procede de preparation de dispersions de nanoparticules cristallines |
| WO2005014069A1 (fr) * | 2003-08-05 | 2005-02-17 | Phoqus Pharmaceuticals Limited | Revetement de dispositifs chirurgicaux |
Non-Patent Citations (1)
| Title |
|---|
| See also references of WO2006113309A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006113309A1 (fr) | 2006-10-26 |
| EP1868577A1 (fr) | 2007-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2472542B (en) | Nanoparticles | |
| DE602006017073D1 (en) | Aspartylproteasehemmer | |
| PL1858635T3 (pl) | Proszek mikrokapsułkowy | |
| GB0523969D0 (en) | Inductivwe component | |
| EP1973837A4 (fr) | Nanoparticules lipidiques | |
| DE602006003064D1 (en) | Tripeptid- und tetrapeptid-thioether | |
| EP1977992A4 (fr) | Particule nanosemiconductrice | |
| GB0608938D0 (en) | Particulate material | |
| GB0624980D0 (en) | Modification | |
| DE602006009835D1 (en) | Nthalten | |
| DE602006014261D1 (en) | Benzimidazolverbindungen | |
| GB0526176D0 (en) | Particle binding | |
| EP1862192A4 (fr) | Inhalateur | |
| EP2121726A4 (fr) | Particules protéiques | |
| EP1953216A4 (fr) | Particule composite | |
| GB0510461D0 (en) | Assay particles | |
| EP1868577A4 (fr) | Particules de lacidipine | |
| GB0518478D0 (en) | Particles | |
| DE502006004337D1 (en) | Strangführungsrolle | |
| DE502006007734D1 (en) | Thiazolcarbonsäureanilide | |
| GB0511532D0 (en) | Particulate materials | |
| GB0507303D0 (en) | Particles | |
| GB0403262D0 (en) | Particles | |
| GB0625626D0 (en) | Particles | |
| GB0511123D0 (en) | Substances |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20071025 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: NASARE, VIJAY DINANATHJI Inventor name: SINGH, GURVINDER Inventor name: GHOSH, ARUNAVA Inventor name: MISHRA, MAMTA Inventor name: PANDIT, ANIRUDDHA BHALACHANDRA Inventor name: GOLDWYN, ADOLF CEASER Inventor name: KOMAREDDY, RAVI KUMAR Inventor name: JAWLEKAR, SUHAS LALITADAS Inventor name: DEVARKONDA, SURYA NARAYANA Inventor name: NARASAPUR, SHARAT PANDURANGHOUSE NO. 8-7-193/47, " Inventor name: KHARKAR, MANOJ RAMESH Inventor name: SUNDARAM, VENKATARAMAN |
|
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20091111 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/455 20060101ALI20091105BHEP Ipc: A61K 31/435 20060101ALI20091105BHEP Ipc: A61K 9/20 20060101ALI20091105BHEP Ipc: A61K 9/16 20060101ALI20091105BHEP Ipc: A61K 9/14 20060101AFI20061110BHEP |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: DR. REDDY'S LABORATORIES INC. Owner name: DR. REDDY'S LABORATORIES LTD. |
|
| 17Q | First examination report despatched |
Effective date: 20100319 |
|
| TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
| 17Q | First examination report despatched |
Effective date: 20111004 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20120215 |